BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$0.93
-0.03 (-3.26%)
Open$0.95
Previous Close$0.96
Day High$0.99
Day Low$0.86
52W High$100.80
52W Low—
Volume—
Avg Volume79.5K
Market Cap4.90M
P/E Ratio—
EPS$-79.31
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+714.7% upside
Current
$0.93
$0.93
Target
$7.59
$7.59
$6.77
$7.59 avg
$11.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.17M | 1.16M | 1.19M |
| Net Income | -2,390,864,439 | -117,803 | -121,826 |
| Profit Margin | -26,074.4% | -10.2% | -10.2% |
| EBITDA | -2,547,384,014 | -246,829 | -223,977 |
| Free Cash Flow | — | -166,595 | -168,575 |
| Rev Growth | — | +16.9% | +20.6% |
| Debt/Equity | — | 0.36 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |